Michael Magro

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Coronary Angiography after Cardiac Arrest without ST-Segment Elevation

Jorrit S. Lemkes, Gladys N. Janssens, Nina W. van der Hoeven et al. · New England Journal of Medicine · 2019 · 514 citations · Full text

Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents

Lorenz Räber, Michael Magro, Giulio Stefanini et al. · Circulation · 2012 · 364 citations · Full text

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial

Elvin Kedhi, Balázs Berta, Tomasz Roleder et al. · European Heart Journal · 2021 · 262 citations · Full text

Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study

Michael Magro, Sjoerd T. Nauta, Cihan Şimşek et al. · American Heart Journal · 2011 · 122 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Outcomes Research +8